Skip to main content

Advertisement

SpringerLink
Log in

Expression of ADAMTS12 in Colorectal Cancer-Associated Stroma Prevents Cancer Development and Is a Good Prognostic Indicator of Colorectal Cancer

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Aim

The aim of this study was to investigate the role of ADAMTS12 in colorectal cancer progression and to examine whether ADAMTS-12 can be considered as a prognostic indicator for colorectal cancer.

Methods

This study was performed on formalin-fixed paraffin-embedded resected specimens obtained from 112 patients with colorectal cancer. The expression level of ADAMTS12 was investigated by immunohistochemical staining to assess the relationship between ADAMTS12 expression and the clinicopathologic factors and to study the prognostic significance of ADAMTS12 in colorectal cancer patients.

Results

ADAMTS12 expression was mainly localized in the fibroblasts adjacent to the tumor cells or in macrophages in front of the invasive cancer margins. The ADAMTS12 expression was significantly correlated with the tumor histological grade, depth of tumor invasion, lymph node metastasis, and Dukes’ stage. Patients with low or no ADAMTS12 expression in the tumor stroma had a significantly poor overall survival or disease-free survival.

Conclusion

The expression of ADAMTS12 in colorectal cancer stroma plays an important role in inhibiting tumor development. Patients with ADAMTS12 expression showed better prognosis than those without ADAMTS12 expression. Thus, ADAMTS12 expression may be a good prognostic marker for colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70.

    Article  PubMed  CAS  Google Scholar 

  2. Freije JM, Balbin M, Pendas AM, Sanchez LM, Puente XS, Lopez-Otin C. Matrix metalloproteinases and tumor progression. Adv Exp Med Biol. 2003;532:91–107.

    Article  PubMed  CAS  Google Scholar 

  3. Illemann M, Bird N, Majeed A, et al. MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases. Mol Cancer Res. 2006;4:293–302.

    Article  PubMed  CAS  Google Scholar 

  4. Apte SS. A disintegrin-like and metalloproteases (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. Int J Biochem Cell Biol. 2004;36:981–985.

    Article  PubMed  CAS  Google Scholar 

  5. Cal S, Obaya AJ, Llamazares M, Garabaya C, Quesada V, Lopez-Otin C. Cloning, expression analysis, and tructural characterization of seven novel human DAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains. Gene. 2002;283:49–62.

    Article  PubMed  CAS  Google Scholar 

  6. Porter S, Clark IM, Kevorkian L, Edwards DR. The ADAMTS etalloproteinases. Biochem J. 2005;386:15–27.

    Article  PubMed  CAS  Google Scholar 

  7. Balbin M, Fueyo A, Tester AM, et al. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet. 2003;35:252–257.

    Article  PubMed  CAS  Google Scholar 

  8. Lopez-Otin C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nat Rev Cancer. 2007;7:800–808.

    Article  PubMed  CAS  Google Scholar 

  9. Lind GE, Kleivi K, Meling GI, et al. ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. Cell Oncol. 2006;28:259–272.

    PubMed  CAS  Google Scholar 

  10. Dunn JR, Panutsopulos D, Shaw MW. METH-2 silencing and promoter hypermethylation in NSCLC. Br. J Cancer. 2004;91:1149–1154.

    CAS  Google Scholar 

  11. Lo PH, Leung AC, Kwok CY, et al. Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9. Oncogene. 2007;26:148–157.

    Article  PubMed  CAS  Google Scholar 

  12. Jin H, Wang X, Ying J, et al. Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas. Oncogene. 2007;26:7490–7498.

    Article  PubMed  CAS  Google Scholar 

  13. Cal S, Arguelles JM, Fernandez PL. and Lopez-Otin, C: Identification, characterization, and intracellular processing of ADAM-TS12, a novel human disintegrin with a complex structural organization involving multiple thrombospondin-1 repeats. J Biol Chem. 2001;276:17932–17940.

    Article  PubMed  CAS  Google Scholar 

  14. Liu CJ, Kong W, Xu K, et al. ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein. J Biol Chem. 2006;281:15800–15808.

    Article  PubMed  CAS  Google Scholar 

  15. Llamazares M, Obaya AJ, Moncada-Pazos A, et al. The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signaling pathway. J. Cell ScI. 2007;120:3544–3552.

    Article  CAS  Google Scholar 

  16. Moncada-Pazos A, Obaya AJ, Fraga MF, et al. The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer. J Cell Sci. 2009;15:2906–2913.

    Article  Google Scholar 

  17. Zhou D, Pan G, Zheng C, Zheng J, Yian L, Teng X. Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues. BMC Cancer. 2008;8:353.

    Article  PubMed  Google Scholar 

  18. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3:23–35.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Colorectal Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine/SRRSH, 3 East Qingchun Road, 310006, Hangzhou, Zhejiang, People’s Republic of China

    Da Wang & Chao He

  2. Biomedical Center, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China

    Da Wang, Fu-Biao Zhang & Chao He

  3. Department of Pathology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China

    Tao Zhu

Authors
  1. Da Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tao Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fu-Biao Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chao He
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chao He.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, D., Zhu, T., Zhang, FB. et al. Expression of ADAMTS12 in Colorectal Cancer-Associated Stroma Prevents Cancer Development and Is a Good Prognostic Indicator of Colorectal Cancer. Dig Dis Sci 56, 3281–3287 (2011). https://doi.org/10.1007/s10620-011-1723-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-011-1723-x

Keywords

Search

Navigation